Concepedia

Tim Beaumont

TB

Statistics

Publications

30

Citations

4.3K

H-Index

24

Active since

2000

Affiliations

AIMM Therapeutics (Netherlands)(Current)

Amsterdam UMC Location University of Amsterdam

University of Amsterdam

Sanquin

Amsterdam University Medical Centers

Tim Beaumont is an author at AIMM Therapeutics (Netherlands) specializing in life sciences, immunology, and infectious diseases.

ORCID

Publications per year

2000–2023

30

Publications

30

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Jason S. McLellan, Man Chen, Michael Joyce et al. · Science · 2013 · 1.1K citations · Full text

, , +17

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Jason S. McLellan, Man Chen, Sherman S. Leung et al. · Science · 2013 · 866 citations · Full text

, , +17

CD20 deficiency in humans results in impaired T cell–independent antibody responses

Taco W. Kuijpers, Richard J. Bende, Paul A. Baars et al. · Journal of Clinical Investigation · 2009 · 374 citations · Full text

, , +17

Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming

Mark J. Kwakkenbos, Sean A. Diehl, Etsuko Yasuda et al. · Nature Medicine · 2009 · 302 citations · Full text

, , +14

STAT3-Mediated Up-Regulation of BLIMP1 Is Coordinated with BCL6 Down-Regulation to Control Human Plasma Cell Differentiation

Sean A. Diehl, Heike Schmidlin, Maho Nagasawa et al. · The Journal of Immunology · 2008 · 221 citations · Full text

, , +17

1–5 of 30